Full-Time
Accelerates clinical trials for life sciences
No salary listed
Mid, Senior
United States
Candidates must be based in the PST or MST time zones and will be required to travel for site visits across the US.
Upload your resume to see how it matches 1 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
Lindus Health focuses on speeding up clinical trials to help patients access new treatments more quickly. The company operates differently from traditional contract research organizations (CROs) by using a fixed-price model for studies and milestone-based payments, which aligns their incentives with those of their clients. Lindus Health combines a skilled clinical operations team with a specialized software platform and access to a vast database of 30 million Electronic Health Records. They handle all aspects of clinical studies, including designing the study, recruiting patients, capturing clinical data, monitoring progress, and managing projects. By doing so, Lindus Health has successfully assisted over 90 sponsors in conducting clinical trials across the US, UK, and Europe, achieving results up to three times faster than conventional CROs and often completing trials ahead of schedule.
Company Size
51-200
Company Stage
Series B
Total Funding
$78.7M
Headquarters
London, United Kingdom
Founded
2021
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Unlimited Paid Time Off
Flexible Work Hours
Mental Health Support
Enhanced Parental Leave
Professional Development Budget
Cycle to work scheme
Stock Options
Regular team events
A new laptop as your main workstation
Lindus Health awarded funding from ARIA to build safe and reliable AI for clinical trial design.
CDISC is collaborating with Lindus Health, which is utilizing its proprietary AI technology, to accelerate the generation of Biomedical Concepts across both the CDISC Foundational Standards as well as the Therapeutic Area Standards.
Lindus Health, a London-based startup, has raised $55 million in a Series B funding round led by Balderton Capital, with participation from Creandum, Firstminute, Seedcamp, and Visionaries Club. The company aims to revolutionize clinical trials using AI and automation, facilitating faster drug market entry. Lindus Health plans to relocate its global headquarters to the US, expand its commercial team, and enhance AI-driven clinical trial data analysis.
Lindus Health, a NYC-based clinical trial company, raised $55M in Series B funding led by Balderton Capital, with participation from Visionaries Club and existing investors Creandum, Firstminute, and Seedcamp. The funds will enhance their AI technology and eClinical platform, Citrus™, for optimizing study design and data monitoring. Since its 2021 launch, Lindus Health has conducted 42 trials, enrolling over 36,000 patients in North America and Europe.
NEW YORK, Dec. 10, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has launched their "all-in-one" contract research organization (CRO), site, and technology offering bespoke to the unique needs of cardiovascular clinical trials.Cardiovascular disease is the leading cause of death in both men and women as well as most racial groups in the US. Clinical trials for these conditions require large, diverse participant populations to capture variability in disease presentation and risk factors, along with extended follow-up to assess long-term outcomes and quality of life improvements. Implementing patient-centric approaches in these studies, like remote-monitoring or decentralized trial designs, is also critical to reduce barriers to participation and observe how these interventions perform in the real world. Lindus Health's latest offering equips sponsors with all the necessary resources to navigate these distinct challenges and more that come with conducting clinical trials in the cardiovascular space.To date, Lindus Health has enrolled over 8,000 patients in cardiovascular studies across the US, UK, and EU. Their "All-in-One Cardiovascular CRO" includes end-to-end CRO and site services, industry knowledge, and eClinical technology necessary for sponsors developing therapies and devices to treat and monitor cardiovascular indications."Patient experience is paramount in cardiovascular studies," said Meri Beckwith, co-founder at Lindus Health